More Information Coming Soon!

Product Test Data

Our Data

Aphex™ Independent Lab Product Test Data

Killing germs is a serious business. At Aphex BioCleanse Systems, we back our products with independent lab testing. Our products are tested continually in order to assure the high-quality results our customers expect and deserve. At Aphex™, we develop complete protective systems for many industries and each of our products is put through a rigorous series of tests to maintain our high standards.

To request more information on product independent test data, please email


    Supply Chain Experts

    Our team has decades of experience in supply chain management on a global scale

    Innovation Leaders

    Our executive team members have extensive experience in product innovation at Fortune 500 companies

    Value Builders

    Utilizing a solid fiscal strategy, our team members work to build value for our shareholders every day




    Aphex BioCleanse Systems was founded to provide the world with a much-needed safe and effective alternative to alcohol-based cleaning solution, and with the recent Covid-19 pandemic, we are continually motivated towards this commitment.  Through our water-based products, our mission is to make the world a healthier and safer place by providing the most effective and safest cleaning solutions available.

    We aim to help save lives, ease the burden of illness, increase workforce productivity, and in general, keep homes around the globe clean and safe. From consumer to industrial use, our products can help you save money, protect those you love by cleaning. As an added bonus, we are committed to making Aphex BioCleanse Systems, Inc. the new benchmark in effective environmentally friendly technologies.


    Headquartered in Rochester, New York with a manufacturing facility in Port Richey, Florida, Aphex BioCleanse Systems, Inc. is positioned to service hundreds of thousands of U.S. and Canadian customers quickly and efficiently. Through “Aphex Europe with Qurexx”, our European distribution partners, we are able to establish an international presence and sell our American-made products globally. We look forward to expanding into new markets in the coming years.


    David Olund, Executive Vice President

    David Olund, Executive Vice President of Aphex, has found his niche in leading publicly-traded pharmaceutical companies to success. During his 40-year career in finance, Olund has consulted for multinational corporations, created financial products and helped take them to market and spent over a decade guiding OTC-traded pharmaceutical companies. He was chosen to serve as a regional financial consultant for Leiman American Express at just 23 years old and founded his own boutique financial planning firm at 24. In more recent years, David has consulted for Universal Administration Corp and Zapvir, Inc. At Aphex, Olund guides the company’s financial strategy, including executing its financing plan and merger and leads Aphex’s business development.

    Scott Smith, BioFoam™ Founder and Chief Sustainability Officer

    Smith is an experienced business executive and Harvard Business School Graduate. He is the named inventor on 6 issued patents and 14 patent-pending applications relating to BioFoam™ and HY-IQ® for testing/remediation of water contaminated from algae, viruses, bacteria, oil, and other harmful chemicals.  In 2008, Smith received the United States Small Business Administration Phoenix Award for Disaster Recovery. His mission to educate and foster an understanding of how individuals, businesses, and institutions can create a safer world through protective strategies that rid the world of toxins is unequaled. Smith holds degrees from Baylor University and Harvard Business School (MBA).

    Anthony Marotti, Senior Vice President of Investor Relations

    With Aphex BioCleanse Systems in various capacities since the beginning, Anthony’s position as Senior Vice President of Investor Relations allows him to bring his eclectic experience and intimate knowledge of Aphex to serve our investors. Anthony gained a diverse knowledge of business, technology, and interpersonal relationships through the businesses he founded and/or held C-Level positions in, which include: Design/Build (within the architectural and engineering industry), Software Development, CAD/CAM (systems design, sales, and deployment), Educational Film/Video Production, Corporate Training (within the pharmaceutical industry), to name a few. Anthony’s experience and his long relationship with Aphex is a tremendous asset within his position of heading up Investor Relations.

    Mark Washo, Senior Vice President of Marketing and Sales

    Mark Washo currently serves as the Vice President of Marketing and Sales for Aphex Biocleanse Systems. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team. His previous professional titles include Chief Marketing Officer of the Washington Spirit, President, General Manager and Board of Governor of the WPS Washington Freedom, Executive Vice President of the Chicago Fire Soccer Club, Senior Vice President of the New York-New Jersey MetroStars (Red Bull NY), Senior Director of Ticket Sales at D.C. United, Ticket Sales Executive at the Washington Wizards, and Direct Marketing Representative at Bison Baseball.


    Investor Information

    Interested in investment opportunities? Get in touch with us and we’ll get back to you on how you can get involved.